Certara, Inc. (CERT) Financial Ratios
8 years of historical data (2018–2025) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
↓
10.94
↓-84% vs avg
5yr avg: 67.30
30Y Low15.9·High74.6
P/FCF
↓
10.86
↓-70% vs avg
5yr avg: 36.39
30Y Low14.9·High139.9
P/B Ratio
↓
0.94
↓-61% vs avg
5yr avg: 2.41
30Y Low1.3·High6.3
ROE
↑
-0.2%
↓+88% vs avg
5yr avg: -1.3%
30Y Low-8%·High1%
Debt/EBITDA
↓
0.15
↓-98% vs avg
5yr avg: 6.70
30Y Low0.1·High19.8
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CERT Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Certara, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 10.9x P/FCF, 70% below the 5-year average of 36.4x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.0B | $1.4B | $1.7B | $2.8B | $2.6B | $4.3B | $5.2B | — | — |
| Enterprise Value | $849M | $1.2B | $1.8B | $2.9B | $2.6B | $4.4B | $5.2B | — | — |
| P/E Ratio → | -626.00 | — | — | — | 173.92 | — | — | — | — |
| P/S Ratio | 2.45 | 3.37 | 4.44 | 7.89 | 7.63 | 14.88 | 21.18 | — | — |
| P/B Ratio | 0.94 | 1.33 | 1.61 | 2.67 | 2.37 | 4.09 | 6.27 | — | — |
| P/FCF | 10.86 | 14.94 | 21.67 | 34.52 | 28.11 | 82.71 | 139.90 | — | — |
| P/OCF | 10.66 | 14.67 | 21.23 | 33.78 | 27.67 | 70.52 | 115.12 | — | — |
P/E links to full P/E history page with 30-year chart
CERT EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Certara, Inc.'s enterprise value stands at 10.9x EBITDA, 84% below its 5-year average of 67.3x. The Healthcare sector median is 14.1x, placing the stock at a 23% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.95 | 4.78 | 8.08 | 7.84 | 15.31 | 21.30 | — | — |
| EV / EBITDA | 10.94 | 15.92 | 27.77 | 187.18 | 30.97 | 74.64 | 282.90 | — | — |
| EV / EBIT | 40.38 | — | 424.56 | — | 72.06 | 325.44 | — | — | — |
| EV / FCF | — | 13.06 | 23.35 | 35.36 | 28.89 | 85.09 | 140.66 | — | — |
CERT Profitability
Margins and return-on-capital ratios measuring operating efficiency
Certara, Inc. earns an operating margin of 5.0%. Operating margins have expanded from -11.5% to 5.0% over the past 3 years, signaling improving operational efficiency. A negative ROE of -0.2% indicates the company is currently destroying shareholder equity. ROIC of 1.5% represents below-average returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.5% | 61.5% | 59.9% | 60.2% | 60.5% | 61.0% | 58.6% | 61.7% | 56.6% |
| Operating Margin | 5.0% | 5.0% | -0.4% | -11.5% | 9.7% | 4.7% | -10.0% | 9.4% | -2.8% |
| Net Profit Margin | -0.4% | -0.4% | -3.1% | -15.6% | 4.4% | -4.6% | -20.3% | -4.3% | -20.3% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -0.2% | -0.2% | -1.1% | -5.2% | 1.4% | -1.4% | -7.5% | -1.8% | -6.7% |
| ROA | -0.1% | -0.1% | -0.8% | -3.5% | 1.0% | -1.0% | -4.3% | -0.9% | -3.2% |
| ROIC | 1.5% | 1.5% | -0.1% | -2.7% | 2.1% | 1.0% | -2.1% | 1.7% | -0.4% |
| ROCE | 1.5% | 1.5% | -0.1% | -2.8% | 2.3% | 1.0% | -2.3% | 2.0% | -0.5% |
CERT Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Certara, Inc. carries a Debt/EBITDA ratio of 0.1x, which is very conservative (95% below the sector average of 3.3x). The company holds a net cash position — cash of $189M exceeds total debt of $11M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.29 | 0.29 | 0.29 | 0.30 | 0.36 | 0.82 | 0.83 |
| Debt / EBITDA | 0.15 | 0.15 | 4.70 | 19.78 | 3.63 | 5.25 | 16.33 | 6.56 | 12.62 |
| Net Debt / Equity | — | -0.17 | 0.13 | 0.06 | 0.07 | 0.12 | 0.03 | 0.76 | 0.80 |
| Net Debt / EBITDA | -2.29 | -2.29 | 2.00 | 4.42 | 0.84 | 2.09 | 1.53 | 6.08 | 12.26 |
| Debt / FCF | — | -1.88 | 1.68 | 0.83 | 0.79 | 2.38 | 0.76 | 13.05 | 3706.50 |
| Interest Coverage | — | — | -0.08 | -1.78 | 1.83 | 0.81 | -0.97 | 0.70 | -0.17 |
Net cash position: cash ($189M) exceeds total debt ($11M)
CERT Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Certara, Inc.'s current ratio of 2.05x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 2.62x to 2.05x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.05 | 2.05 | 2.13 | 2.62 | 3.32 | 2.98 | 4.60 | 1.39 | 1.05 |
| Quick Ratio | 2.05 | 2.05 | 2.13 | 2.62 | 3.32 | 2.98 | 4.60 | 1.39 | 0.97 |
| Cash Ratio | 1.23 | 1.23 | 1.23 | 1.81 | 2.29 | 2.01 | 3.60 | 0.46 | 0.18 |
| Asset Turnover | — | 0.27 | 0.24 | 0.23 | 0.21 | 0.19 | 0.19 | 0.20 | 0.16 |
| Inventory Turnover | — | — | — | — | — | — | — | — | 12.84 |
| Days Sales Outstanding | — | 90.22 | 112.85 | 96.06 | 96.57 | 99.90 | 97.12 | 91.65 | 111.21 |
CERT Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Certara, Inc. returns 4.2% to shareholders annually primarily through share buybacks.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 0.6% | — | — | — | — |
| FCF Yield | 9.2% | 6.7% | 4.6% | 2.9% | 3.6% | 1.2% | 0.7% | — | — |
| Buyback Yield | 4.2% | 3.0% | 0.5% | 0.2% | 0.1% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 4.2% | 3.0% | 0.5% | 0.2% | 0.1% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $160M | $160M | $159M | $159M | $150M | $153M | $157M | $132M |
Peer Comparison
Compare CERT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CERTYou | $1B | -626.0 | 10.9 | 10.9 | 61.5% | 5.0% | -0.2% | 1.5% | 0.1 |
 MEDP | $12B | 27.9 | 21.2 | 17.9 | 30.1% | 21.1% | 70.2% | 154.9% | 0.4 |
 IQV | $30B | 22.5 | 12.9 | 14.6 | 26.3% | 14.0% | 21.4% | 8.7% | 4.7 |
 CRL | $9B | -62.5 | 13.0 | 17.3 | 30.5% | 12.6% | -4.3% | 6.3% | 3.4 |
 VEEV | $27B | 30.8 | 28.2 | 19.2 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 |
 SLP | $320M | -4.9 | — | 18.4 | 58.4% | -89.3% | -42.1% | -39.6% | — |
 SDGR | $970M | -9.2 | — | 77.9 | 55.7% | -65.2% | -26.3% | -39.4% | — |
 RXRX | $2B | -2.4 | — | — | -62.0% | -867.9% | -59.5% | -95.8% | — |
 EXLS | $5B | 20.1 | 13.7 | 16.2 | 38.4% | 15.0% | 27.2% | 20.4% | 1.1 |
 PFE | $151B | 19.5 | 10.7 | 16.6 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 |
 MRK | $280B | 15.6 | 10.8 | 22.7 | 72.0% | 36.2% | 36.9% | 22.0% | 1.7 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
See CERT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CERT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CERT vs MEDP
Side-by-side business, growth, and profitability comparison vs Medpace Holdings, Inc..
Start ComparisonCERT — Frequently Asked Questions
Quick answers to the most common questions about buying CERT stock.
What is Certara, Inc.'s P/E ratio?
Certara, Inc.'s current P/E ratio is -626.0x. The historical average is 173.9x.
What is Certara, Inc.'s EV/EBITDA?
Certara, Inc.'s current EV/EBITDA is 10.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 37.3x.
What is Certara, Inc.'s ROE?
Certara, Inc.'s return on equity (ROE) is -0.2%. The historical average is -2.8%.
Is CERT stock overvalued?
Based on historical data, Certara, Inc. is trading at a P/E of -626.0x. Compare with industry peers and growth rates for a complete picture.
What are Certara, Inc.'s profit margins?
Certara, Inc. has 61.5% gross margin and 5.0% operating margin.
How much debt does Certara, Inc. have?
Certara, Inc.'s Debt/EBITDA ratio is 0.1x, indicating low leverage. A ratio below 2x is generally considered financially healthy.